Jason Gray, MD
Orthopaedic Surgery · Anchorage, AKNPI 1255691671
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Arthrex at 37.8% of the total. Reporting peaked in 2023 at $6,666 and has fallen 53.5% since, to $3,100 in 2025.
Across 151 payments — averaging $113.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$6K
- Stryker$6K
- Johnson & Johnson$2K
- Summit Surgical Corp.$1K
- Alaska Medical Technologies, LLC$583
- Medical Device Business Services, Inc.$203
- plus $637 from 10 others
What the payments were for
- Travel & lodging$9,48055%
- Food & beverage$5,75734%
- Education$1,92511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 58 | $6,492 |
| Stryker | 59 | $6,442 |
| Johnson & Johnson | 4 | $1,570 |
| Summit Surgical Corp. | 9 | $1,235 |
| Alaska Medical Technologies, LLC | 1 | $583 |
| Medical Device Business Services, Inc. | 5 | $203 |
| Axogen | 1 | $107 |
| Acumed LLC | 4 | $97 |
| Smith+Nephew | 2 | $95 |
| Endo Pharmaceuticals Inc. | 2 | $95 |
| Heron Therapeutics, Inc. | 1 | $84 |
| Skeletal Dynamics Inc | 1 | $70 |
| Abbott | 1 | $25 |
| Bioventus LLC | 1 | $21 |
| Tenex Health Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,162 in reported general payments places this provider in the 85th percentile of 63 orthopaedic surgery providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 51 | $281 |
| Celecoxib | 28 | $226 |
| Ketorolac Tromethamine | 22 | $137 |
| Ibuprofen | 34 | $137 |
| Oxycodone Hcl | 33 | $134 |
| Mupirocin | 18 | $122 |
| Tramadol Hcl | 26 | $43 |
| IbuIbuprofen | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Anchorage
- Bryan HaughomAnchorage$179K
- Benjamin PackardAnchorage$40K
- Kenneth ThomasAnchorage$35K
- Ian BrimhallAnchorage$17K
- Thomas PaynterAnchorage$14K
- Kevin PaisleyAnchorage$10K
- Daniel CepelaAnchorage$9K
- Lars MatkinAnchorage$9K
- Adam EllisonAnchorage$8K
- Bradley SparksAnchorage$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.